The Asia-Pacific trauma fixation devices market is predicted to reach USD 1.38 Billion by 2023 from USD 0.94 Billion in 2018, growing at a CAGR of 7.91%. Trauma is a condition caused by various strains or physical injuries, such as dislocation, fractures, or burns due to external sources. Currently, to treat trauma various treatments are available based on the severity of injury. Trauma fixation devices are one of the key treatment methods for the aforementioned medical conditions.
With the rising geriatric population, the demand for trauma fixation devices is expected to increase as the aged people are more prone to osteoporosis, which employ trauma fixation devices for treatment. Further, the increase in disposable incomes of people, favourable government policies, and advancements in medical facilities, increase in healthcare expenditure, high cost and complications associated with surgeries and hospital bed time are contributing to the growth of Asia-Pacific trauma fixation devices market.
However, compatibility issues associated with usage of internal trauma devices and the high cost of advanced technologies are inhibiting the reach of the trauma fixation devices in these region.
The Asia-Pacific trauma fixation devices market is segmented on the basis of type into internal and external fixation devices. Under internal fixation devices, Screws, Plates, Rods, Wires and Intramedullary nails are included. And the external trauma fixation devices are categorized on the basis of technology into Unilateral, Circular and Hybrid Fixation. The internal trauma fixation devices segment holds the largest share of the Asia-Pacific market. Moreover, the demand for better services in trauma surgeries is compelling the manufacturers to develop products that are minimally invasive and more anatomical, such as low-profile plating system for extremity fixation procedures.
Furthermore, on the basis of geography the Asia-Pacific market for trauma fixation devices is analysed under various countries namely, India, China, Japan, South Korea and Australia. The rise in geriatric population and personal disposable income of people in Asian countries such as China and India are contributing to the market growth in these emerging nations.
The Asia-Pacific trauma fixation devices market is a competitive market with a number of market players which is dominated by new product launches, mergers & acquisitions.Some of the major players are Stryker Corporation, Smith & Nephew, DePuy Synthesis, Zimmer, Medtronic, Inc., Biomet, Arthrex, Conmed, Integra Lifesciences Corporation and Bioretec, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Internal trauma fixation devices
5.1.1.1 Screws
5.1.1.2 Rods
5.1.1.3 Plates
5.1.1.4 Wires
5.1.1.5 Intramedullary nails
5.1.2 External Trauma fixation devices
5.1.2.1 Unilateral fixation
5.1.2.2 Circular fixation
5.1.2.3 Hybrid fixation
5.2 By End Users
5.2.1 Hospitals
5.2.2 Point of Care testing
5.2.3 Others
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Arthrex
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Biomet
8.3 Conmed
8.4 DePuy Synthesis
8.5 Smith & Nephew
8.6 Stryker Corporation
8.7 Integra Lifesciences Corporation
8.8 Zimmer
8.9 Bioretec, Inc.
8.10 Medtronic, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
